Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › New Albany › NPI 1689857385
Hospital

Physicians Medical Center LLC

Physicians Medical Center LLC was paid $11.35M by Medicaid between Jan 2018 and Oct 2024, across 128 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 53% of everything it billed.

33Billing provider infoPHYSICIANS MEDICAL CENTER LLC
NEW ALBANY, IN 47150
33aNPI1689857385assigned 12/17/2007
28Total paid$11.35M
24GClaims321,026
24DCodes billed128
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers

Next to other General Acute Care Hospital providers in Indiana

Rank by total paid#32 of 69
Median peer was paid$9.76M
This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018312,648$9.86M
20191,660$292K
20201,713$339K
20211,535$286K
20221,358$317K
20231,243$158K
2024incomplete869$102K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 53% 37,845 18,857 $6.05M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 9.7% 25,248 13,893 $1.10M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 4.9% 927 745 $557K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 3.8% 3,729 2,691 $433K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 2.1% 6,475 5,606 $233K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.0% 6,474 5,605 $222K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.0% 6,757 5,686 $222K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1.9% 150 107 $211K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 1.6% 243 181 $185K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 1.5% 136 98 $166K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.4% 2,869 1,959 $161K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.1% 5,258 4,572 $126K
116 more codes
87522 Neg quan hep c or qual rna 1.0% 2,759 $117K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,465 $84K
84443 Thyroid stimulating hormone (TSH) <1% 4,899 $82K
64483 <1% 160 $81K
80053 Comprehensive metabolic panel <1% 7,827 $72K
80074 <1% 1,371 $65K
80367 <1% 2,072 $61K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 672 $56K
86803 <1% 3,983 $55K
64493 <1% 145 $54K
87341 <1% 5,172 $52K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 6,717 $51K
82607 <1% 3,192 $47K
43235 <1% 100 $47K
84481 <1% 2,952 $46K
86705 <1% 3,911 $44K
86709 <1% 3,650 $39K
80368 <1% 5,773 $29K
62323 <1% 94 $26K
80333 <1% 1,206 $25K
86704 <1% 1,659 $22K
43450 <1% 181 $21K
80364 <1% 785 $21K
80363 <1% 5,217 $21K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 23 $20K
86708 <1% 1,391 $19K
83992 <1% 6,179 $18K
84439 <1% 2,002 $18K
84436 <1% 2,529 $18K
84480 <1% 1,118 $17K
80061 Lipid panel <1% 1,250 $14K
80361 <1% 6,395 $13K
80323 <1% 5,983 $12K
86780 <1% 912 $12K
36415 Collection of venous blood by venipuncture <1% 5,975 $12K
80346 <1% 5,934 $10K
82746 <1% 886 $10K
80356 <1% 6,395 $10K
80365 <1% 6,395 $10K
80348 <1% 6,177 $9K
80354 <1% 6,178 $9K
20610 <1% 76 $9K
64494 <1% 144 $9K
80373 <1% 6,178 $9K
80372 <1% 6,160 $9K
83036 Hemoglobin; glycosylated (A1C) <1% 1,027 $9K
80349 <1% 6,127 $9K
81025 <1% 487 $8K
80358 <1% 6,178 $8K
80335 <1% 5,271 $8K
80320 <1% 5,680 $7K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 46 $7K
64484 <1% 41 $7K
80360 <1% 3,065 $7K
80353 <1% 6,196 $6K
80359 <1% 6,178 $6K
80369 <1% 5,300 $6K
80366 <1% 1,626 $6K
80355 <1% 1,626 $6K
80345 <1% 5,711 $6K
84403 <1% 345 $5K
82533 <1% 252 $5K
80370 <1% 436 $5K
86593 <1% 902 $4K
86592 <1% 902 $4K
82670 <1% 282 $4K
80325 <1% 1,393 $4K
87340 <1% 296 $3K
76000 <1% 26 $3K
86376 <1% 272 $3K
82248 <1% 655 $3K
80324 <1% 4,742 $3K
82627 <1% 236 $3K
80371 <1% 873 $3K
84146 <1% 236 $3K
84153 <1% 201 $3K
84270 <1% 259 $3K
83001 <1% 175 $2K
82962 <1% 642 $2K
80332 <1% 4,221 $2K
82150 <1% 189 $2K
83735 <1% 234 $2K
84154 <1% 118 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 19 $1K
82728 <1% 226 $1K
J3490 Unclassified drugs <1% 328 $1K
83540 <1% 240 $1K
84466 <1% 220 $1K
C2617 Stent, non-coronary, temporary, without delivery system <1% 18 $999.92
83690 <1% 187 $864.46
80336 <1% 114 $799.50
84144 <1% 115 $737.28
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 497 $645.03
84402 <1% 59 $598.82
84550 <1% 146 $561.79
83721 <1% 216 $521.90
84702 <1% 35 $515.95
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 1,639 $409.25
80374 <1% 356 $392.90
87086 Culture, bacterial; quantitative colony count, urine <1% 91 $380.90
82043 <1% 50 $324.43
81001 <1% 47 $155.72
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 207 $146.27
83002 <1% 13 $122.22
80362 <1% 58 $102.74
86431 <1% 13 $79.64
85045 <1% 15 $66.30
84100 <1% 13 $61.82
82950 <1% 30 $45.44
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 49 $32.16
85007 <1% 24 $26.59
J1040 Injection, methylprednisolone acetate, 80 mg 0% 645 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 204 $0.00
L8699 Prosthetic implant, not otherwise specified 0% 85 $0.00
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 0% 174 $0.00
77002 0% 94 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMEDLEY, DENNIS (CEO/ADMINISTRATOR)
Same official

Other billing entities under MEDLEY, DENNIS

Full network →
ProviderLocationPaid
Physicians Medical Center LLCNew Albany, IN$266K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.